{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-043419","form_type":"8-K","ticker":"SNWV","cik":"0001417663","company_name":"SANUWAVE Health, Inc.","filed_at":"2026-06-16T12:07:31+00:00","discovered_at":"2026-06-16T12:10:00.418154+00:00","generated_at":"2026-06-16T12:10:12.687398+00:00","sec_items":["7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Sanuwave cuts Q2 2026 revenue guidance to $8.5-9.5M on Ultramist market disruption","bullets":["Revenue guidance for Q2 2026 reduced to $8.5-$9.5M from prior guidance provided on May 13.","Downgrade driven by CMS reimbursement clawbacks causing wound care practice closures and cannibalization from used Ultramist systems.","Applicator consumables on pace for record quarterly unit volume in Q2.","CEO Morgan Frank sees positive applicator outlook but near-term headwinds from capital sales."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-043419","json":"https://secwatch.observer/filing/0001628280-26-043419.json","markdown":"https://secwatch.observer/filing/0001628280-26-043419.md","text":"https://secwatch.observer/filing/0001628280-26-043419.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417663/000162828026043419/0001628280-26-043419-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417663/000162828026043419/snwv-20260616.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T12:10:12.687398+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}